About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Current Drug Discovery Technologies
›
top-articles
Current Drug Discovery Technologies
1.4
(top 50%)
impact factor
695
(top 20%)
papers
10.7K
(top 20%)
citations
46
(top 20%)
h
-index
1.4
(top 50%)
impact factor
823
all documents
11.3K
doc citations
75
(top 20%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Targeted Cancer Therapy: The Next Generation of Cancer Treatment
Current Drug Discovery Technologies
2015
429
2
20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications
Current Drug Discovery Technologies
2011
410
3
Potential Therapeutic Application of Chondroitin Sulfate/Dermatan Sulfate
Current Drug Discovery Technologies
2008
214
4
Development of Multifunctional Nanoparticles for Targeted Drug Delivery and Noninvasive Imaging of Therapeutic Effect
Current Drug Discovery Technologies
2009
211
5
Reversible Covalent Chemistry in Drug Delivery
Current Drug Discovery Technologies
2005
150
6
From in vitro Experiments to in vivo and Clinical Studies; Pros and Cons
Current Drug Discovery Technologies
2016
150
7
Passive and Active Tumour Targeting with Nanocarriers
Current Drug Discovery Technologies
2011
144
8
New Drug Delivery Systems Based on Chitosan
Current Drug Discovery Technologies
2008
126
9
Merging Traditional Chinese Medicine with Modern Drug Discovery Technologies to Find Novel Drugs and Functional Foods
Current Drug Discovery Technologies
2010
122
10
Discovery of Medically Significant Lantibiotics
Current Drug Discovery Technologies
2009
115
11
Calixarenes as New Platforms for Drug Design
Current Drug Discovery Technologies
2009
113
12
Preparation and Characterization of Solid Lipid Nanoparticles-A Review
Current Drug Discovery Technologies
2012
103
13
Systemic Delivery of Curcumin: 21st Century Solutions for an Ancient Conundrum
Current Drug Discovery Technologies
2009
99
14
Targeting the Nucleus: An Overview of Auger-Electron Radionuclide Therapy
Current Drug Discovery Technologies
2010
99
15
Multifunctional Porous Silicon for Therapeutic Drug Delivery and Imaging
Current Drug Discovery Technologies
2011
97
16
Discovery of Anticoagulant Drugs: A Historical Perspective
Current Drug Discovery Technologies
2012
96
17
Therapeutic Use of Heparin beyond Anticoagulation
Current Drug Discovery Technologies
2009
90
18
Hepatocytes as a Tool in Drug Metabolism, Transport and Safety Evaluations in Drug Discovery
Current Drug Discovery Technologies
2010
90
19
Silica Materials in Drug Delivery Applications
Current Drug Discovery Technologies
2011
78
20
Assessment of the Health Effects of Chemicals in Humans: I. QSAR Estimation of the Maximum Recommended Therapeutic Dose (MRTD) and No Effect Level (NOEL) of Organic Chemicals Based on Clinical Trial Data1
Current Drug Discovery Technologies
2004
77
21
Design, Synthesis and Potent Pharmaceutical Applications of Glycodendrimers:A Mini Review
Current Drug Discovery Technologies
2007
72
22
Autocorrelation of Molecular Electrostatic Potential Surface Properties Combined with Partial Least Squares Analysis as Alternative Attractive Tool to Generate Ligand-Based 3D-QSARs
Current Drug Discovery Technologies
2005
71
23
Strategies for Compound Selection
Current Drug Discovery Technologies
2004
71
24
Ion Channel Drug Discovery and Research: The Automated Nano-Patch- ClampO Technology
Current Drug Discovery Technologies
2004
69
25
Current In Vitro Kinase Assay Technologies: The Quest for a Universal Format
Current Drug Discovery Technologies
2008
69
26
Quercetin-Phospholipid Complex: An Amorphous Pharmaceutical System in Herbal Drug Delivery
Current Drug Discovery Technologies
2012
68
27
Bivalent Ligands as Specific Pharmacological Tools for G Protein-Coupled Receptor Dimers
Current Drug Discovery Technologies
2008
67
28
Molecular Basis of Traditional Chinese Medicine in Cancer Chemoprevention
Current Drug Discovery Technologies
2010
66
29
Diabetes Beyond Insulin: Review of New Drugs for Treatment of Diabetes Mellitus
Current Drug Discovery Technologies
2007
65
30
Surface Photochemistry: Organic Molecules within Nanocavities of Calixarenes
Current Drug Discovery Technologies
2007
64
31
Emergence of Nanomedicine as Cancer Targeted Magic Bullets: Recent Development and Need to Address the Toxicity Apprehension
Current Drug Discovery Technologies
2012
63
32
Therapeutic Potential of Citronella Essential Oil: A Review
Current Drug Discovery Technologies
2019
61
33
Natures Medicines: Traditional Knowledge and Intellectual Property Management. Case Studies from the National Institutes of Health (NIH), USA
Current Drug Discovery Technologies
2005
56
34
NMR-Based Quality Control Approach for the Identification of False Positives and False Negatives in High Throughput Screening
Current Drug Discovery Technologies
2006
56
35
QSAR Modeling of Carcinogenic Risk Using Discriminant Analysis and Topological Molecular Descriptors
Current Drug Discovery Technologies
2005
55
36
Chitosan Formulations as Carriers for Therapeutic Proteins
Current Drug Discovery Technologies
2011
55
37
Is Phage Display Technology on Target for Developing Peptide-Based Cancer Drugs?
Current Drug Discovery Technologies
2004
54
38
Current Treatment of Autoimmune Blistering Diseases
Current Drug Discovery Technologies
2009
54
39
Update on Nitazoxanide: A Multifunctional Chemotherapeutic Agent
Current Drug Discovery Technologies
2018
54
40
Crosslinked, Polymerized, and PEG-Conjugated Hemoglobin-Based Oxygen Carriers: Clinical Safety and Efficacy of Recent and Current Products
Current Drug Discovery Technologies
2012
53
41
Mechanisms of Antimicrobial Resistance (AMR) and Alternative Approaches to Overcome AMR
Current Drug Discovery Technologies
2020
53
42
Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids
Current Drug Discovery Technologies
2013
53
43
Controlling Receptor Downregulation by Ubiquitination and Deubiquitination
Current Drug Discovery Technologies
2008
51
44
Hair Growth: Focus on Herbal Therapeutic Agent
Current Drug Discovery Technologies
2015
51
45
SMILES in QSPR/QSAR Modeling: Results and Perspectives
Current Drug Discovery Technologies
2007
50
46
Active Tumor Targeting of Nanomaterials Using Folic Acid, Transferrin and Integrin Receptors
Current Drug Discovery Technologies
2011
50
47
The Oxazolomycins: A Structurally Novel Class of Bioactive Compounds
Current Drug Discovery Technologies
2004
50
48
Probing Protein Binding Sites by Circular Dichroism Spectroscopy
Current Drug Discovery Technologies
2004
50
49
A Retrospect Study on Thiazole Derivatives as the Potential Antidiabetic Agents in Drug Discovery and Developments
Current Drug Discovery Technologies
2018
49
50
Function Oriented Synthesis: The Design, Synthesis, PKC Binding and Translocation Activity of a New Bryostatin Analog
Current Drug Discovery Technologies
2004
48
site/software ©
exaly
; All materials licenced under
CC by-SA
.